ESPRIT: Turning the <120 mmHg Target Into Real-World Practice.
ESPRIT: Turning the <120 mmHg Target Into Real-World Practice.
• New JACC editorial highlights the ESPRIT trial, showing that intensive BP control (SBP <120 mmHg) is feasible even in primary care settings.
• 62.5% of patients achieved intensive BP targets with only ~1.3 additional antihypertensive medications and 1.5 extra clinic visits compared with standard treatment.
• Benefits of intensive BP lowering were consistent regardless of hypertension duration or baseline BP control status.
• Findings support guideline trends favoring more intensive BP control, particularly in high cardiovascular-risk patients.
• Success was attributed to a standardized treatment protocols.
Take-home message: Intensive BP control is not only effective—it can be realistically implemented with modest increases in treatment intensity and follow-up.
Source : Medical News CME, June 2026
Commentary based on the JACC editorial by Yu-Jie Zuo and Ji-Guang Wang (Shanghai, China). DOI: 10.1016/j.jacc.2026.03.041.
https://www.jacc.org/doi/10.1016/j.jacc.2026.03.041